6gid Citations

High resolution crystal structure of substrate-free human neprilysin.

J Struct Biol 204 19-25 (2018)
Cited: 9 times
EuropePMC logo PMID: 29906506

Abstract

Neprilysin is a transmembrane M13 zinc metalloprotease responsible for the degradation of several biologically active peptides including insulin, enkephalin, substance P, bradykinin, endothelin-1, neurotensin and amyloid-β. The protein has received attention for its role in modulating blood pressure responses with its inhibition producing an antihypertensive response. To date, several inhibitor bound crystal structures of the human neprilysin extracellular domain have been determined, but, a structure free of bound inhibitor or substrate has yet to be reported. Here, we report the first crystal structure free of substrate or inhibitor for the extracellular catalytic domain of human neprilysin at 1.9 Å resolution. This structure will provide a reference point for comparisons to future inhibitor or substrate bound structures. The neprilysin structure also reveals that a closed protein conformation can be adopted in protein crystals absent of bound substrate or inhibitor.

Articles - 6gid mentioned but not cited (7)

  1. Molecular Basis for Omapatrilat and Sampatrilat Binding to Neprilysin-Implications for Dual Inhibitor Design with Angiotensin-Converting Enzyme. Sharma U, Cozier GE, Sturrock ED, Acharya KR. J Med Chem 63 5488-5500 (2020)
  2. New Borane-Protected Derivatives of α-Aminophosphonous Acid as Anti-Osteosarcoma Agents: ADME Analysis and Molecular Modeling, In Vitro Studies on Anti-Cancer Activities, and NEP Inhibition as a Possible Mechanism of Anti-Proliferative Activity. Mizerska-Kowalska M, Sowa S, Donarska B, Płaziński W, Sławińska-Brych A, Tomasik A, Ziarkowska A, Łączkowski KZ, Zdzisińska B. Int J Mol Sci 23 6716 (2022)
  3. Actions of Novel Angiotensin Receptor Blocking Drugs, Bisartans, Relevant for COVID-19 Therapy: Biased Agonism at Angiotensin Receptors and the Beneficial Effects of Neprilysin in the Renin Angiotensin System. Moore GJ, Ridgway H, Kelaidonis K, Chasapis CT, Ligielli I, Mavromoustakos T, Bojarska J, Matsoukas JM. Molecules 27 4854 (2022)
  4. Albumin-neprilysin fusion protein: understanding stability using small angle X-ray scattering and molecular dynamic simulations. Kulakova A, Indrakumar S, Sønderby Tuelung P, Mahapatra S, Streicher WW, Peters GHJ, Harris P. Sci Rep 10 10089 (2020)
  5. Endoplasmic Reticulum Associated Degradation of Spinocerebellar Ataxia-Related CD10 Cysteine Mutant. Kanuka M, Ouchi F, Kato N, Katsuki R, Ito S, Miura K, Hikida M, Tamura T. Int J Mol Sci 21 E4237 (2020)
  6. Structures of soluble rabbit neprilysin complexed with phosphoramidon or thiorphan. Labiuk SL, Sygusch J, Grochulski P. Acta Crystallogr F Struct Biol Commun 75 405-411 (2019)
  7. In silico study of inhibitory capacity of sacubitril/valsartan toward neprilysin and angiotensin receptor. Jovanović JĐ, Antonijević M, Vojinović R, Filipović ND, Marković Z, Marković Z. RSC Adv 12 29719-29726 (2022)


Reviews citing this publication (2)